Doctors have said that self-medication is dangerous, especially in these times that the pandemic is still in our midst. Just because someone recommended a certain type of medication does not mean it’s effective and safe, not unless they are doctors. Dr. Edsel Maurice Salvaña, Adult Infectious Disease Specialist, Director, Institute…
Spectrum Health Doctor remains participant in Johnson & Johnson vaccine clinical trials
and last updated 2021-03-09 17:51:11-05
GRAND RAPIDS, Mich. â A doctor at Spectrum Health is part of the ongoing Johnson & Johnson vaccine clinical trial.
Back in December, 2020, Dr. Liam Sullivan, DO an Adult Infectious Disease Specialist at Spectrum Health signed up and was accepted into Johnson & Johnson s clinical vaccine trial.
He said, âThey give you an injection and they donât tell you which you get because itâs a randomized double-blinded trial, so they donât know and I donât know what I got.â
Based on his bodyâs reaction, Dr. Sullivan was sure heâd gotten the actual vaccine, not a placebo. He said he just didnât feel great the next day and progressively got more tired as the day went on. He also reported waking up with body aches and a low-grade fever the day after that. Overall, the symptoms lasted between 24-36 hours.
Health systems expect slow start to vaccinating new 50+ with health conditions eligibility group
and last updated 2021-03-08 17:44:21-05
WEST MICHIGAN â Michiganâs vaccine eligibility expanded Monday, March 8 to include those 50 years and older with underlying health conditions, as well as caregivers.
While that group can start signing up depending on where you live, health experts say you may still be waiting a bit to actually get your shot.
âJust because it opened up, doesnât mean everywhere that they will be able to get a vaccine right away,â explained Eric Pessell, the Health Officer for the Calhoun County Public Health Department.
DAVAO CITY, March 5 (PIA) - Health Secretary Francisco Duque III allayed fears that the AstraZeneca vaccines is not effective against the South African variant of the Covid-19 Virus.
He stressed the data is not enough to conclude that the AstraZeneca vaccine has a low efficacy rate against any variant.
Duque said the AstraZeneca vaccine has 100 percent efficacy rate in preventing severe to critical cases of the COVID-19 infection.
“We are after a vaccine that will guarantee lesser severe and critical cases which ensure lesser hospitalization, at kung walang maoospital, walang mamamatay,” he pointed out.
Duque said based on experience, those who died from the COVID-19 infection where from severe to critical cases.